A detailed history of State Street Corp transactions in Geron Corp stock. As of the latest transaction made, State Street Corp holds 22,548,467 shares of GERN stock, worth $96.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,548,467
Previous 31,604,392 28.65%
Holding current value
$96.3 Million
Previous $104 Million 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.1 - $5.09 $28.1 Million - $46.1 Million
-9,055,925 Reduced 28.65%
22,548,467 $95.6 Million
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $10.5 Million - $20.6 Million
5,978,786 Added 23.33%
31,604,392 $104 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $442,344 - $587,250
254,221 Added 1.0%
25,625,606 $54.1 Million
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $8.64 Million - $13.4 Million
4,093,323 Added 19.24%
25,371,385 $53.8 Million
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $8.43 Million - $15.8 Million
-4,279,539 Reduced 16.74%
21,278,062 $68.3 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $12.5 Million - $19.9 Million
5,845,412 Added 29.65%
25,557,601 $55.5 Million
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $12.6 Million - $15 Million
6,204,477 Added 45.93%
19,712,189 $47.7 Million
Q3 2022

Nov 15, 2022

SELL
$1.67 - $2.94 $13,699 - $24,116
-8,203 Reduced 0.06%
13,507,712 $31.6 Million
Q2 2022

Aug 15, 2022

SELL
$1.19 - $1.65 $3,492 - $4,842
-2,935 Reduced 0.02%
13,515,915 $21 Million
Q1 2022

May 16, 2022

BUY
$0.99 - $1.6 $1.58 Million - $2.55 Million
1,593,868 Added 13.37%
13,518,850 $18.4 Million
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $1.23 Million - $1.73 Million
-1,004,475 Reduced 7.77%
11,924,982 $14.5 Million
Q3 2021

Nov 15, 2021

SELL
$1.2 - $1.5 $815,114 - $1.02 Million
-679,262 Reduced 4.99%
12,929,457 $17.7 Million
Q2 2021

Aug 16, 2021

SELL
$1.25 - $1.83 $3.77 Million - $5.52 Million
-3,015,661 Reduced 18.14%
13,608,719 $19.2 Million
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $4.66 Million - $6.44 Million
3,067,221 Added 22.62%
16,624,380 $26.3 Million
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.05 $2.96 Million - $3.91 Million
1,909,521 Added 16.39%
13,557,159 $21.6 Million
Q3 2020

Nov 10, 2020

BUY
$1.59 - $2.19 $12.1 Million - $16.7 Million
7,640,921 Added 190.7%
11,647,638 $20.3 Million
Q2 2020

Aug 14, 2020

BUY
$1.05 - $2.18 $287,282 - $596,452
273,602 Added 7.33%
4,006,717 $8.74 Million
Q1 2020

May 11, 2020

BUY
$0.89 - $1.49 $3.32 Million - $5.56 Million
3,733,115 New
3,733,115 $4.44 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.61B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.